DRIVE MEDICAL, INC
CLAREMONT, CA
What changed
NIH R35 · $0.4M · Mimics of Enzymes and Antibodies for Glycans and Other Biological Targets
3mo agoGrant renewalApr 2, 2026Source filing (opens the source filing in a new tab)
Momentum
Momentum 46 out of 100, unchanged since the last recompute.
Some recent activity, at a steady rate.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R43 · $316k · non-dilutive
Sep 8, 2025DRIVE MEDICAL, INC · PI ZHAO, YAN SHI · NIDDK · award ends Aug 31, 2027 · A robotic enteroscope for safe and effective access to the small bowel
NIH RePORTER · NIH RePORTER 11252691 (opens the source filing in a new tab)
- Grant
R35 · $383k · non-dilutive
Apr 15, 2025IOWA STATE UNIVERSITY · PI ZHAO, YAN · NIGMS · award ends Mar 31, 2030 · Mimics of Enzymes and Antibodies for Glycans and Other Biological Targets
NIH RePORTER · NIH RePORTER 11321532 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources